Literature DB >> 2566933

Effect of omega-conotoxin GVIA on release of 3H-gamma-aminobutyric acid from slices of rat neostriatum.

A Thate1, D K Meyer.   

Abstract

omega-Conotoxin GVIA (omega-CT) diminished the potassium-induced in vitro release of 3H-gamma-aminobutyric acid (3H-GABA) from slices of rat neostriatum in a manner which depended on the concentration of potassium. omega-CT (0.1 mmol/l) decreased the release of 3H-GABA induced by 25 mmol/l K+ from 11.6% to 6.1% of tissue content, ie. by 48%, while it did not affect the release of 3H-GABA caused by 20 mmol/l K+, which was 4.8% of tissue content. However, in the presence of a polyclonal antiserum or cysteamine (600 mumol/l), both of which diminish the effects of endogenous somatostatin, 0.1-10 nmol/l omega-CT decreased the release of 3H-GABA induced by 20 mmoles/l K+ by 40%. It is concluded that omega-CT did not only inhibit GABA-neurones, but had an additional inhibitory effect on somatostatin neurones which are known to depress the release of 3H-GABA. It is further concluded that neuronal interactions, which are possible in brain slice preparations, may impede the interpretation of effects of drugs, especially if agents are used which affect basic mechanisms of transmitter release and thus the release of various transmitters from neurones.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566933     DOI: 10.1007/BF00173592

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurons.

Authors:  L D Hirning; A P Fox; E W McCleskey; B M Olivera; S A Thayer; R J Miller; R W Tsien
Journal:  Science       Date:  1988-01-01       Impact factor: 47.728

2.  Inhibition of central neurotransmitter release by omega-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium channel.

Authors:  D J Dooley; A Lupp; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

3.  Peptide neurotoxins from fish-hunting cone snails.

Authors:  B M Olivera; W R Gray; R Zeikus; J M McIntosh; J Varga; J Rivier; V de Santos; L J Cruz
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

4.  Spontaneous and potassium-evoked release of 3H-GABA newly synthesized from 3H-glutamine in slices of the rat substantia nigra.

Authors:  M L Kemel; C Gauchy; J Glowinski; M J Besson
Journal:  Life Sci       Date:  1979-06-04       Impact factor: 5.037

5.  Omega-conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release.

Authors:  D J Dooley; A Lupp; G Hertting; H Osswald
Journal:  Eur J Pharmacol       Date:  1988-03-29       Impact factor: 4.432

6.  Cysteamine-induced decrease of somatostatin in rat brain synaptosomes in vitro.

Authors:  R Widmann; G Sperk
Journal:  Endocrinology       Date:  1987-10       Impact factor: 4.736

7.  A venom peptide with a novel presynaptic blocking action.

Authors:  L M Kerr; D Yoshikami
Journal:  Nature       Date:  1984 Mar 15-21       Impact factor: 49.962

8.  Effects of cysteamine on pro-somatostatin related peptides.

Authors:  C Bakhit; R Benoit; F E Bloom
Journal:  Regul Pept       Date:  1983-05

9.  A study of synaptic transmission in the absence of nerve impulses.

Authors:  B Katz; R Miledi
Journal:  J Physiol       Date:  1967-09       Impact factor: 5.182

10.  Brain voltage-sensitive calcium channel subtypes differentiated by omega-conotoxin fraction GVIA.

Authors:  I J Reynolds; J A Wagner; S H Snyder; S A Thayer; B M Olivera; R J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more
  1 in total

1.  Effects of the putative P-type calcium channel blocker, R,R-(-)-daurisoline on neurotransmitter release.

Authors:  P C Waldmeier; P Wicki; W Fröstl; H Bittiger; J J Feldtrauer; P A Baumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.